Pyxis Historical Financial Ratios
| PYXS Stock | USD 1.09 0.06 5.22% |
Pyxis Oncology is promptly reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.35, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.64 will help investors to properly organize and evaluate Pyxis Oncology financial condition quickly.
Pyxis |
About Pyxis Financial Ratios Analysis
Pyxis OncologyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pyxis Oncology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pyxis financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pyxis Oncology history.
Pyxis Oncology Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Pyxis Oncology stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pyxis Oncology sales, a figure that is much harder to manipulate than other Pyxis Oncology multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Ev To Operating Cash Flow
A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.Most ratios from Pyxis Oncology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pyxis Oncology current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pyxis Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.At this time, Pyxis Oncology's Debt To Equity is comparatively stable compared to the past year. Graham Net Net is likely to gain to 1.94 in 2025, whereas Operating Cash Flow Per Share is likely to drop (1.04) in 2025.
| 2024 | 2025 (projected) | Payables Turnover | 0.0978 | 0.0929 | Days Of Inventory On Hand | 156.38 | 139.0 |
Pyxis Oncology fundamentals Correlations
Click cells to compare fundamentals
Pyxis Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pyxis Oncology fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (28.95) | 1.35 | 0.28 | 0.57 | 0.76 | 0.79 | |
| Book Value Per Share | (0.46) | 8.11 | 4.87 | 3.15 | 2.07 | 2.35 | |
| Free Cash Flow Yield | (0.0255) | (0.1) | (2.16) | (1.08) | (0.64) | (0.67) | |
| Operating Cash Flow Per Share | (0.29) | (1.1) | (2.7) | (1.77) | (0.99) | (1.04) | |
| Pb Ratio | (28.95) | 1.35 | 0.28 | 0.57 | 0.76 | 0.79 | |
| Free Cash Flow Per Share | (0.34) | (1.11) | (2.9) | (1.94) | (0.99) | (1.04) | |
| Roic | (1.81) | (0.29) | (0.67) | (0.55) | (0.62) | (0.65) | |
| Net Income Per Share | (0.37) | (2.53) | (3.57) | (1.85) | (1.32) | (1.39) | |
| Cash Per Share | 0.24 | 8.53 | 5.43 | 2.99 | 2.17 | 2.66 | |
| Pocfratio | (44.91) | (10.01) | (0.5) | (1.02) | (1.58) | (1.66) | |
| Pfcf Ratio | (39.15) | (9.86) | (0.46) | (0.93) | (1.57) | (1.65) | |
| Income Quality | 0.79 | 0.46 | 0.74 | 0.96 | 0.75 | 0.6 | |
| Roe | 0.82 | (0.31) | (0.73) | (0.59) | (0.64) | (0.61) | |
| Ev To Operating Cash Flow | (44.19) | (2.23) | 1.3 | (1.18) | (1.59) | (1.67) | |
| Pe Ratio | (35.49) | (4.34) | (0.38) | (0.97) | (1.18) | (1.24) | |
| Return On Tangible Assets | (1.26) | (0.29) | (0.56) | (0.49) | (0.5) | (0.53) | |
| Ev To Free Cash Flow | (38.52) | (2.2) | 1.21 | (1.08) | (1.59) | (1.67) | |
| Earnings Yield | (0.0282) | (0.23) | (2.66) | (1.03) | (0.85) | (0.89) | |
| Current Ratio | 2.2 | 14.9 | 5.9 | 4.84 | 7.49 | 11.41 | |
| Tangible Book Value Per Share | (0.46) | 8.11 | 4.87 | 2.54 | 2.02 | 2.26 | |
| Shareholders Equity Per Share | (0.46) | 8.11 | 4.87 | 3.15 | 2.07 | 2.35 | |
| Graham Net Net | (0.52) | 7.95 | 3.92 | 1.79 | 1.55 | 1.94 | |
| Interest Debt Per Share | 0.0227 | 0.005121 | 0.57 | 0.53 | 0.35 | 0.2 | |
| Price Earnings Ratio | (35.49) | (4.34) | (0.38) | (0.97) | (1.18) | (1.24) | |
| Price Book Value Ratio | (28.95) | 1.35 | 0.28 | 0.57 | 0.76 | 0.79 | |
| Price To Operating Cash Flows Ratio | (44.91) | (10.01) | (0.5) | (1.02) | (1.58) | (1.66) | |
| Price To Free Cash Flows Ratio | (39.15) | (9.86) | (0.46) | (0.93) | (1.57) | (1.65) | |
| Ebt Per Ebit | 0.99 | 1.09 | 0.98 | 0.9 | 0.89 | 1.07 | |
| Effective Tax Rate | 0.005145 | (0.0732) | 0.0229 | 0.0272 | 0.0313 | 0.0329 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pyxis Stock Analysis
When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.